Global Artificial Pancreas Devices Systems Competitive Landscape Professional Research Report 2024

Global Artificial Pancreas Devices Systems Competitive Landscape Professional Research Report 2024

Research Summary

An artificial pancreas device system (APDS) is an advanced and integrated technology that replaces the normal function of the pancreas in diabetic patients. This device is designed to automate and personalize insulin delivery through a closed-loop system. It consists of three essential components: a continuous glucose monitoring system (CGM), an insulin pump, and a control algorithm. The continuous glucose monitoring system continuously tracks glucose levels, and the algorithm automatically adjusts the amount of insulin being delivered through the insulin pump to maintain the ideal glucose level in the patient＇s bloodstream. Thus, this device can provide real-time monitoring and precise insulin delivery, resulting in improved glucose control, reduced risk of hypoglycemia, and enhanced quality of life for people with diabetes.

According to DIResearch's in-depth investigation and research, the global Artificial Pancreas Devices Systems market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Artificial Pancreas Devices Systems include Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Artificial Pancreas Devices Systems. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Artificial Pancreas Devices Systems market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Artificial Pancreas Devices Systems market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Artificial Pancreas Devices Systems industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Artificial Pancreas Devices Systems Include:

Medtronic

Bigfoot Biomedical

Beta Bionics

Admetsys

Insulet

Tandem Diabetes Care

Defymed

Artificial Pancreas Devices Systems Product Segment Include:

Threshold Suspended Device Systems

Hybrid Closed-loop APDS

Other Systems

Artificial Pancreas Devices Systems Product Application Include:

Hospitals

Clinics

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Artificial Pancreas Devices Systems Industry PESTEL Analysis

Chapter 3: Global Artificial Pancreas Devices Systems Industry Porter’s Five Forces Analysis

Chapter 4: Global Artificial Pancreas Devices Systems Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Artificial Pancreas Devices Systems Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Artificial Pancreas Devices Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Artificial Pancreas Devices Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Artificial Pancreas Devices Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Artificial Pancreas Devices Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Artificial Pancreas Devices Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Artificial Pancreas Devices Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Artificial Pancreas Devices Systems Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources